Share

December 2021; 11 (6) Commentary

Health Care Disparities Add Insult to Spinal Cord Injury

Miguel X. Escalon, Amy Houtrow, Felicia Skelton, Monica Verduzco-Gutierrez
First published April 16, 2021, DOI: https://doi.org/10.1212/CPJ.0000000000001095
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
88

Share

Article Information

vol. 11 no. 6 e893-e895
DOI: 
https://doi.org/10.1212/CPJ.0000000000001095
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received September 15, 2020
  • Accepted March 9, 2021
  • First Published April 16, 2021.

Article Versions

Copyright & Usage: 
© 2021 American Academy of Neurology

Author Disclosures

    1. Miguel X. Escalon, MD, MPH,
    2. Amy Houtrow, MD, PhD, MPH,
    3. Felicia Skelton, MD, MS and
    4. Monica Verduzco-Gutierrez, MD
  1. Miguel X. Escalon, MD, MPH,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 90DPTB0009 - 9/30/2017 – 9/29/2022 NIDILRR: Administration for Community Living $ 258,407.00 Title: The New York Traumatic Brain Injury (TBI) Model System at Mount Sinai Role: Co-Investigator 90SI5017 - 9/30/2016 - 9/29/2021 NIDILRR - Administration for Community Living $ 291,716.00 Title: Mount Sinai Spinal Cord Injury Model Systems Role: Co-Investigator 18-0362-00001-01 - 9/30/2016 - 9/29/2021 The Bronx Veterans Medical Research Foundation Inc. (Sub only) $ 21,836.00 NCE Title: Dose Response to the Norepinephrine Precursor Droxidopa in Hypotensive Individuals with Spinal Cord Injury Role: Site principal-Investigator

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Amy Houtrow, MD, PhD, MPH,
    3. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. 1) Archives of Physical Medicine and Rehabilitation, section editor, 5 years2) Disability and Health, editorial board, 4 years3) Academic Pediatrics, editorial board, 1 year

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Tissue Tech -consultancy for Spina Bifida research

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH/NICHDMOMS2: Follow up of the Management 2012-2018U01HD068541of Myelomeningocele StudyProject Director (12%) $7,890,000CDCNational Spina Bifida Registry 2014-2022U01DD000737-07Co-I (2%) $180,000PCORIEarly Rehabilitation Protocol in the PICU2014-2017CER 1310-08343For Children with Acute Brain InjuryCo-I (5%) $1,870,000Health Resources Leadership Education in Neurodevelopmental2016-2021and Services AdministrationDisabilities and Other Related DisabilitiesHRSA 16-031Co-I/ Faculty (12.5%) $600,000PA Department of HealthTechnology Assisted Children?s Home Program2016-2021Bureau of Family HealthPI (2.5%) $718,2504100073989

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Felicia Skelton, MD, MS and
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 2017/11/01-2022/10/31 VA HSR&D Career Development Award-2 (Historically Black Colleges and University Research Scientist Training Program)1 IK2 HX002484-04 Skelton, Felicia (PI) Optimizing Bacteriuria Management in Veterans with Spinal Cord Injury Exploring patient, provider, and environment factors driving current urine testing and treatment practices, with the goal of developing an intervention to minimize unnecessary testing and antibiotic use. Role: PI 2019/3/1-2023/28/2 VA RR&D Merit Review Trautner, Barbara W. (PI) Bacteriophage to treat multidrug-resistant UTI in persons with spinal cord injury, I01RX002595-01A2 We will be developing phage for a specific clinical application, to manage the resistant pathogens causing UTI in persons with spinal cord injury. Role: Co-Investigator 2020/10/1-2021/9/30 2020/10/1-2021/9/30 VA Office of Rural Health Skelton, Felicia and Touchette, Hilary (Co-PI) Supporting Telehealth for Rural Disabled Veterans: Creating an Implementation Toolkit In this project, we will create educational resources (SCI Fact Sheet and Implementation Toolkit) that provides guidance and resources to support implementation of video telehealth for rural veterans with disability from Spinal Cord Injuries and Disorders (SCI/D) by interviewing Veterans with SCI/D, SCI/D medical providers, and mental health providers who are interested in serving this population. Role: Co-PI

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Monica Verduzco-Gutierrez, MD
    5. Scientific Advisory Boards:

    1. (1) Ipsen (2) Allergan / AbbVie (3) Medtronic (4) Merz

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Ipsen, financial payment (2) Allergan / AbbVie, financial payment (3) Medtronic, financial payment, flight (4) Merz, financial payment, flight

    Editorial Boards:

    1. (1) American Journal of Physical Medicine and Rehabilitation, Social Media Editor, 2018-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Ipsen (2) Allergan / AbbVie (3) Medtronic (4) Merz (5) Piramal

    Speakers' Bureaus:

    1. (1) Ipsen (2) Allergan / AbbVie (3) Medtronic (4) Merz

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Rehabilitation and Human Performance. Icahn School of Medicine at Mount Sinai. New York (MXE), NY; Department of Physical Medicine and Rehabilitation (AH), University of Pittsburgh School of Medicine, Pittsburgh, PA; Center for Innovations in Quality (FS), Effectiveness and Safety, Michael E. DeBakey VA Medical Center, Houston, TX; H. Ben Taub Department of Physical Medicine and Rehabilitation (FS), Baylor College of Medicine, Houston, TX; and Department of Rehabilitation Medicine (MV-G), Lozano Long School of Medicine at the University of Texas Health Science Center at San Antonio, San Antonio, TX.
  1. Correspondence
    Dr. Escalon miguelxescalonmd{at}gmail.com
View Full Text

Article usage

Article usage: April 2021 to April 2023

AbstractFullPdfSource
Apr 202112705Highwire
May 20218103Highwire
Jun 202116407Highwire
Jul 2021114017Highwire
Aug 202176011Highwire
Sep 20219306Highwire
Oct 20217502Highwire
Nov 20212401Highwire
Dec 2021285113Highwire
Jan 202219085Highwire
Feb 2022173158Highwire
Mar 20225121Highwire
Apr 202214033Highwire
May 20228601Highwire
Jun 20223902Highwire
Jul 20224203Highwire
Aug 20223311Highwire
Sep 202211202Highwire
Oct 20224300Highwire
Nov 20227500Highwire
Dec 20227630Highwire
Jan 20234121Highwire
Feb 20233401Highwire
Mar 20233214Highwire
Apr 20232201Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me